Stem Cells
We study the role of stem cells in physiological or pathological conditions, including cancer. We aim to find biomarkers that allow to detect cancer stem cell phenotypes, as well as the influence of cellular/molecular elements from the microenvironment in determining such phenotypes. Among other tools, we take advantage of cell reprogramming technology to be able to go further into the determination of stem cell-states independently of the cell’s original physiopathological context.
Research area laboratories
Proteoglycan and Extracellular Matrix Chemistry
Dr. Juan Carlos Calvo
Molecular Oncology and New Therapeutic Targets
Dra. Adriana De Siervi
Nuclear Receptors
Dr. Mario D. Galigniana
Pharmaceutical Biotechnology
Dr. Gustavo Helguera
Hormonal Carcinogenesis
Dra. Claudia Lanari
Hormones and Cancer
Dra. Isabel Alicia Lüthy
Molecular and Functional Glycomics
Dra. Karina V. Mariño
Studies of the Physiopathology of the Ovary
Dra. María Fernanda Parborell
Glycomedicine
Dr. Gabriel Adrian Rabinovich
Tumor Immunology
Dra. Roxana Schillaci
Pathology and Molecular Pharmacology
Dra. Carina Shayo
Tumor Physiology and Biology of the Ovary
Dra. Marta Tesone
Cell-Cell Interaction Studies in Reproduction and Cancer
Dra. Mónica Hebe Vazquez-Levin
Stem Cells
Dr. Norma Alejandra Chasseing / Dr. Juan Carlos Calvo
